|
Real-time Estimate
Cboe BZX
20:31:18 12/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 38.02 USD | -1.76% |
|
-9.96% | +7.15% |
| 08-10 | Cogent Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-10 | Cogent Biosciences Q2 Loss Widens | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
COGT 38.17 $
-1.37%
21.56M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| COGT | 38.17USD | -1.37% | 21.56M $ | |
CBOE
| COGT | 38.13USD | -1.57% | 876K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 42.84 | 42.84 | 42.39 |
| Spread/Res. | -11.16% | -11.16% | -10.21% |
| Spread/Supp. | +1.60% | +1.60% | +68.96% |
| Support | 37.46 | 37.46 | 22.53 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- COGT Stock
- Charts Cogent Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
